Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2011 / Cilt: 8 - Sayı: 4

The value of colposcopy, high risk HPV-DNA and histopathologic examination in the management of abnormal pap smear results

Anormal pap smear sonucu yönetiminde kolposkopi, yüksek riskli HPV-DNA ve histopatolojik incelemenin önemi

Pages
272–278
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, the management of patients with H-SIL colposcopic biopsy would be the best approach.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Pap smear test is a major screening test for early diagnosis and treatment of cervix cancer.
📊
Key Findings & Data:The study compromised 86 patients with smear results of ASCUS, AGC, L-SIL and H-SIL.
💡
Conclusion & Impact:However, the management of patients with H-SIL colposcopic biopsy would be the best approach.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Pap smear test is a major screening test for early diagnosis and treatment of cervix cancer. The aim of our study was to assess the value of HPV-DNA, colposcopy and histopathologic examination in the management of patients with abnormal cervical cytology. Materials and methods: This prospective cohort study was conducted in Ankara University Cebeci Hospital gynecology outpatient clinic. The study compromised 86 patients with smear results of ASCUS, AGC, L-SIL and H-SIL. Age, gravity, parity, age at first coitus, smoking status, number of partners, high risk HPV-DNA status and pathologic colposcopy findings were investigated. Results: Mean age of the patients was 35 years and the most common abnormal smear result was ASCUS, with 55 patients (63%). There was no significant difference between the groups regarding demographic characteristics except age at first coitus and pathologic colposcopy findings. Among patients diagnosed as ASCUS 34.5% had been upgraded with histopathologic examination. Among patients diagnosed as L-SIL 73.6% had been down-graded with histopathologic examination. However, after the histopathologic exam of 9 H-SIL patients two (22.2%) were diagnosed as CIN II, two (22.2%) were diagnosed as CIN III and one (11.1%) was diagnosed as cervical cancer. In the groups of ASCUS, L-SIL and H-SIL the presence of high risk HPV-DNA were 11%, 5% and 33%, respectively. Conclusion: If we are sure that the patient will attend the follow-up visits, a repeat smear test would be the appropriate in management of ASCUS and L-SIL cervical smear pathology. However, the management of patients with H-SIL colposcopic biopsy would be the best approach.

Özet

Amaç: Pap smear testi serviks kanserinin erken tanı ve tedavisinde çok önemli bir tarama yöntemidir. Bu çalışmanın amacı, smear testinde anormallik saptanan olguların yönetiminde HPV-DNA, kolposkopi ve patolojik incelemenin öneminin belirlenebilmesidir. Gereç ve yöntemler: Bu prospektif kohort çalışma 2005-2007 yılları arasında Ankara Üniversitesi Cebeci Hastanesi jinekoloji polikliniğinde yürütülmüştür. Çalışmaya smear sonuçları ASCUS, AGC, L-SIL ve H-SIL olan 86 hasta dahil edilmiştir. Gruplarda yaş, gravida, parite, ilk koitus yaşı, sigara kullanım durumu, partner sayısı, yüksek riskli HPVDNA pozitişiği ve patolojik kolposkopi bulguları karşılaştırılmıştır. Bulgular: Hastaların ortalama yaşı 35 ve en sık anormal smear sonucu 55 hastada (%63) ASCUS'tur. Demografik özelliklerden sadece ilk koitus yaşı ve patolojik kolposkopi bulguları açısından gruplar arasında fark saptanmıştır. ASCUS saptanan hastaların %34.5'inde patolojik inceleme ile daha ileri bir tanı izlenmiştir. L-SIL saptanan hastaların ise %73.6'sında daha basit bir tanıya gerileme izlenmiştir. Dokuz H-SIL hastasının ise ikisinde (%22.2) CIN II, ikisinde (%22.2) CIN III ve birinde (%11.1) serviks kanseri izlenmiştir. ASCUS, L-SIL ve H-SIL gruplarında yüksek riskli HPV-DNA pozitliği sırasıyla %11, %5 ve %33 olarak tespit edilmiştir. Sonuç: Pap smear testinde ASCUS ve L-SIL saptandığında eğer hasta uyumundan eminsek yönetimde smear tekrarı ile takip uygundur. H-SIL saptanan hastalarda kolposkopik biyopsi uygun yaklaşım olacaktır.

🔖

Cite This Article

ŞÜKÜR, Y. E., TEZCAN, S., BAYRAMOV, V. (2022). The value of colposcopy, high risk HPV-DNA and histopathologic examination in the management of abnormal pap smear results. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 8 - Sayı: 4, 272–278. https://ajindex.com/articles/631614

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Jones BA, Davey DD. Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med 2000; 124 (5): 672- 81
  2. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004; 364 (9430): 249- 56
  3. Liu S, Semenciw R, Probert A, Mao Y. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer 2001; 11 (1): 24- 31
  4. Taylor RJ, Morrell SL, Mamoon HA, Wain GV. Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort. J Epidemiol Community Health 2001; 55 (11): 782- 8
  5. Walsh JME. Cervical cancer: developments in screening and evaluation of the abnormal Pap smear. West J Med 1998; 169 (5): 304- 10
  6. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH for the 1992 National Cancer Institute Workshop. Interim guidelines for management of abnormal cervical cytology. JAMA 1994; 271 (23): 1866- 9
  7. The Bethesda System for reporting cervical/vaginal cytological diagnoses: revised after the second National Cancer Institute Workshop, April 29- 30, 1991. Acta Cytol. 1993; 37 (2): 115- 24
  8. Covell JI, Wilbur DC, Guidos B, Lee KR, Chhieng DC, Mody DR. Epithelial Abnormalities: Glandular. In: The Bethesda System for Reporting Cervical Cytology: deinitions, criteria and explanatory notes. Solomon D, Nayar R, eds. Second edition, New York: Springer Science + Business Media, Inc.; 2004. P. 123- 56
  9. Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2000; 124 (2): 203-11
  10. Schiffman M, Solomon D. Findings to date from the ASCUSLSIL triage study (ALTS). Arch Pathol Lab Med. 2003; 127 (8): 946- 9
  11. Castle PE, Cox JT, Schiffman M, Wheeler CM, Solomon D. Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology. Obstet Gynecol. 2008; 112 (3): 637- 45
  12. Yetimalar H, Köksal A, ‹nceo¤lu M, Kasap B. Premalign ve malign servikal lezyonlu hastalarda HPV enfeksiyonu. TJOD Derg 2009; 6 (4): 273- 8
  13. Ergünay K, Misirlioglu M, Firat P, Tuncer ZS, Tuncer S, Yildiz I, Ustaçelebi S. Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical s